With COVID-19 vaccine stocks Pfizer and Moderna receiving so much attention, the author of today’s article notes that “This leaves a lot of biotech stocks lacking the attention they deserve. While this is bad news for current holders of these stocks, it is an opportunity for new ones.” With this in mind, he proceeds to highlight three “under-loved” biotech stocks with more upside potential than downside risk to consider for profits in 2021. For these three stocks, CLICK HERE.
3 “Under-Loved” Biotech Stocks With More Upside Potential Than Downside Risk
Tags:2021 ProfitsBiotech InvestmentsBiotech StocksCOVID-19 VaccineinvestmentinvestorModernaPfizerStock Marketstocks